IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 2,575,107 units at a public offering price of $2.33 per unit. Each unit consists of one common share (or pre-funded warrant to…
Mon, 10 Mar 2025 05:49:00 GMT ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S.
Sun, 16 Feb 2025 04:17:00 GMT Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (“ReShape” or the “Company ... 895-3745 or by email at [email protected]. This press release shall not constitute an offer to sell or a ...
Sat, 15 Feb 2025 16:00:00 GMT ReShape Lifesciences ® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public ...
Sat, 15 Feb 2025 16:00:00 GMT Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the ...
Fri, 14 Feb 2025 16:01:00 GMT Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (“ReShape ... 895-3745 or by email at syndicate@maximgrp.com. This press release shall not constitute an offer to sell or a ...
